Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-18

Clinical Trial Update: Does Acetylsalicylic Acid Reduce the Mortality of Patients Admitted to an Intensive Care Unit [Phase 3]

View source ↗

Summary

Phase 3 trial investigating whether acetylsalicylic acid (aspirin) reduces mortality in ICU-admitted patients with critical illness; study TERMINATED with poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acetylsalicylic acid (Aspirin)

Snippet

Sponsor: Medical University of Vienna | Conditions: Critical Illness | Phase 3 | Status: TERMINATED | Results posted: 2019-12-18